Cited by 408Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSingle-cell and spatial transcriptomics

SenNet recommendations for detecting senescent cells in different tissues

Open access
Suryadevara, Vidyani, Hudgins, Adam D., Rajesh, Adarsh, Pappalardo, Alberto, Karpova, Alla, Dey, Amit K., Hertzel, Ann, Agudelo, Anthony +71 more·2024·Nature Reviews Molecular Cell Biology

Abstract

Once considered a tissue culture-specific phenomenon, cellular senescence has now been linked to various biological processes with both beneficial and detrimental roles in humans, rodents and other species. Much of our understanding of senescent cell biology still originates from tissue culture studies, where each cell in the culture is driven to an irreversible cell cycle arrest. By contrast, in tissues, these cells are relatively rare and difficult to characterize, and it is now established that fully differentiated, postmitotic cells can also acquire a senescence phenotype. The SenNet Biomarkers Working Group was formed to provide recommendations for the use of cellular senescence markers to identify and characterize senescent cells in tissues. Here, we provide recommendations for detecting senescent cells in different tissues based on a comprehensive analysis of existing literature reporting senescence markers in 14 tissues in mice and humans. We discuss some of the recent advances in detecting and characterizing cellular senescence, including molecular senescence signatures and morphological features, and the use of circulating markers. We aim for this work to be a valuable resource for both seasoned investigators in senescence-related studies and newcomers to the field.

Integrity signals

Registry

Crossref · 10.1038/s41580-024-00738-8

Cites

307 of 307 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

174 of 241 cited sources checked · 62 supported · 2 flagged · accuracy not yet measured

  • Premisecitation

    Senescent podocytes in old mouse kidneys overexpress senescence markers and SASP factors including Irf5, Cebpb, Jdp2, Ccl2, Ccl3, Ccl5, Ccl8, Mmp12, Mmp13 and Gsk3b.

    “Senescent podocytes in old mouse kidneys overexpress senescence markers and SASP factors, including Irf5, Cebpb, Jdp2, Ccl2, Ccl3, Ccl5, Ccl8, Mmp12, Mmp13 and Gsk3b.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [140] Cohen, C. et al. Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1. EMBO Mol. Med. 13, e14146 (2021). source

      The Results section on aging nephropathy reports that p21, a senescence marker, colocalized with an endothelial-cell marker but not with the podocyte marker nephrin in old mouse glomeruli. The SASP Results section reports MMP13 upregulation in whole kidneys, not in senescent podocytes. The paper identifies endothelial-cell senescence and podocyte loss, contrary to the claim's attribution of senescence-marker and SASP overexpression to podocytes; it does not report the claimed gene list in podocytes. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Premisecitation

    During acinar-to-ductal metaplasia, dedifferentiated acinar cells acquire a senescent state characterized by cell cycle arrest, induction of p53, CDKN1A, CDKN2A and SA-β-gal activity.

    “During acinar-to-ductal metaplasia, dedifferentiated acinar cells acquire a senescent state characterized by cell cycle arrest, induction of p53, CDKN1A, CDKN2A and SA-β-gal activity190–193.”
    Quote in the paperNot a substantial claim2 of 4 sources checked
    • cites [190] Grabliauskaite, K. et al. p21WAF1/Cip1 limits senescence and acinar-to-ductal metaplasia formation during pancreatitis. J. Pathol. 235, 502–514 (2015). source
    • cites [191] Horiguchi, M. et al. Senescence caused by inactivation of the homeodomain transcription factor Pdx1 in adult pancreatic acinar cells in mice. FEBS Lett. 593, 2226–2234 (2019). source
    • cites [192] Kim, S. et al. The basic helix–loop–helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential. Pancreas 44, 718–727 (2015). source

      The Abstract says that during oncogenic Kras-driven acinar-to-ductal metaplasia, quiescent acinar cells enter the cell cycle, rather than arrest in a senescent state. The Results report CDKN1A (p21) induction and growth arrest after E47 is introduced into pancreatic cancer cells to drive them back toward an acinar state; they do not establish the claimed senescence-marker pattern during metaplasia. (LLM, conf=0.86)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [193] Tourlakis, M. E. et al. In vivo senescence in the Sbds-deficient murine pancreas: cell-type specific consequences of translation insufficiency. PLoS Genet. 11, e1005288 (2015). source

      The Results sections on postnatal pancreatic senescence and p53 dependence report senescent acinar cells with cell-cycle arrest, SA-β-gal activity, increased p53, and increased Cdkn1a. They report induction of Cdkn2b, not Cdkn2a. The Results section on p53-dependent phenotypes describes morphology consistent with early acinar-to-ductal metaplasia in p53-deficient pancreata, where dedifferentiation markers became widespread; it does not establish that cells acquire this senescent state during metaplasia. Page numbers are unavailable in our copy. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • Findingcitation

    The substantia nigra of individuals with Parkinson disease has reduced SATB1 and increased CDKN2A, MMP3, IL-6, IL-1α, and CXCL8 compared with healthy brains, suggesting increased senescence burden.

    “Compared with brains of healthy individuals, the substantia nigra of individuals with Parkinson disease has reduced levels of SATB1 (a CDKN1A repressor) and increased levels of CDKN2A, MMP3, IL-6, IL-1α and CXCL8, suggesting an increased burden of senescence106,116.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [106] Chinta, S. J. et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease. Cell Rep. 22, 930–940 (2018). source

      The Results section, “Senescent Astrocytes and SASP Factors Are Elevated in Parkinsonian Substantia Nigra Pars Compacta” (page not provided), reports increased p16INK4a, MMP-3, IL-6, IL-1α and IL-8 in Parkinsonian substantia nigra pars compacta tissue compared with controls, and interprets the findings as evidence of increased senescence. The paper does not report reduced SATB1 or identify it as a CDKN1A repressor; a search for SATB1 found no supporting passage. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [116] Brichta, L. et al. Identification of neurodegenerative factors using translatome-regulatory network analysis. Nat. Neurosci. 18, 1325–1333 (2015). source

      The Results section ('Validation of novel determinants of DA neurodegeneration'; page unavailable) reports significantly decreased SATB1 transcriptional activity in substantia nigra samples from people with incipient Parkinson disease versus controls. It explicitly says SATB1 expression levels did not change, contrary to the claimed reduction in levels. Our copy does not report increases in CDKN2A, MMP3, IL-6, IL-1α or CXCL8, or an increased senescence burden. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Interpretationreasoning

    Detecting senescence-associated cell cycle arrest requires quantifying multiple factors and features.

    “Therefore, detecting senescence-associated cell cycle arrest requires quantifying multiple factors and features17.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [17] Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019). source
  • Findingcitation

    Single-cell transcriptomics identified a Cdkn1ahigh senescent-like population from aged mouse adipose tissue-derived mesenchymal stem cells, with upregulation of Il6, Il15, Vegfa, Cxcl2, Ccl2, and Cxcl1.

    “A single-cell transcriptomics study identified a Cdkn1ahigh senescent-like cell population from aged mouse adipose tissue-derived mesenchymal stem cells, with additional upregulation of Il6, Il15, Vegfa, Cxcl2, Ccl2 and Cxcl1 (ref. 124).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [124] Wang, B. et al. Transplanting cells from old but not young donors causes physical dysfunction in older recipients. Aging Cell 19, e13106 (2020). source

      The single-cell transcriptome analysis (section labeled Abstract; no page supplied) identifies a Cdkn1a/p21-high senescent-like ADSC population that is more common in old donors. The paper also reports upregulation of several SASP-related genes in old-donor ADSCs overall, but the passages do not identify Il6, Il15, Vegfa, Cxcl2, Ccl2 and Cxcl1 as upregulated, or establish that this list is specific to the p21-high population. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 22
  • May combine two claims. 61
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Cellular senescence contributes to physiological and pathological processes in humans, mice, and some other species.

    “In humans, mice and some other species, cellular senescence has been shown to contribute to various physiological and pathological processes1.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [1] He, S. & Sharpless, N. E. Senescence in health and disease. Cell 169, 1000–1011 (2017). source
  • May combine two claims.

    Premisecitation

    RB and p53 activation also occurs in other cell cycle arrests, CDKN2A is expressed in some non-senescent cells, and CDKN2A is absent in some senescent cells.

    “Activation of RB and p53 (encoded by TP53 in humans, Trp53 in mice) also occurs in other forms of cell cycle arrest14, and CDKN2A is expressed in certain non-senescent cells15 and is not expressed in all senescent cells16.”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [14] Rodier, F. & Campisi, J. Four faces of cellular senescence. J. Cell Biol. 192, 547–556 (2011). source
    • cites [15] Sharpless, N. E. & Sherr, C. J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 15, 397–408 (2015). source
    • cites [16] Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436–453 (2018). source
  • May combine two claims.

    Premisecitation

    SASP composition and strength vary with senescence duration, stimulus origin, and cell type.

    “The composition and strength of the SASP can vary depending on the duration of senescence, the origin of the senescence stimulus and specific cell types17,21.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [17] Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019). source
    • cites [21] Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290–1301 (2021). source
  • May combine two claims.

    Findingcitation

    Senescent cells in human and mouse adipose tissue express CDKN2A and CDKN1A, have higher SA-β-gal activity, DNA damage foci, proliferation arrest (MKI67), and SASP factors including IL-6, CXCL8, IL-1β, TNF, CCL2, SERPINE1, MMP3, and MMP12.

    “Senescent cells in both human and mouse adipose tissue have been characterized by expression of CDKN2A and CDKN1A, higher SA-β-gal activity, DNA damage (γH2AX) foci and arrest of cell proliferation (MKI67), and by expression of SASP factors including IL-6, CXCL8 (also known as IL-8), IL-1β, TNF, CCL2, SERPINE1, MMP3 and MMP12 (refs. 119–122).”
    Quote in the paperSubstantial claim4 of 4 sources checked
    • cites [119] Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl Acad. Sci. USA 112, E6301–E6310 (2015). source

      The paper’s Significance passage (page unavailable) describes a capillary analogue of muscle contraction, not senescence in adipose tissue. Searches for the adipose-tissue senescence markers and listed SASP factors found no passage addressing the claim in our copy. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [120] Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018). source

      The mouse-adipose Results report increased CDKN2A expression, SA-β-gal-positive cells and telomere-associated DNA-damage foci. The human-adipose Results identify p16INK4A, SA-β-gal and those foci as senescence markers, and report secretion of IL-6, IL-8, MCP-1 and PAI-1 (corresponding to CCL2 and SERPINE1). The cited paper does not establish the claimed CDKN1A or MKI67 markers, or the full listed set of SASP factors, in both human and mouse adipose tissue. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [121] Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell 18, e12950 (2019). source

      The Results (‘Senescent cell clearance improves glucose homeostasis and insulin sensitivity’; page not supplied) identify p16Ink4a- and p21Cip1-expressing senescent cells in mouse adipose tissue. The adipose-tissue methods assay SA-β-gal, and the Results discuss IL-1β, TNF-α and MCP-1. Our copy does not establish the full marker profile in both human and mouse adipose tissue: it does not document γH2AX foci or MKI67 arrest there, or identify CXCL8, SERPINE1, MMP3 and MMP12 as adipose-cell SASP factors. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [122] Wang, L. et al. Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 34, 75–89.e8 (2022). source

      The Introduction and Discussion describe p21-high cells in mouse adipose tissue as having higher SA-β-gal activity, reduced proliferation and a SASP; the paper also examines γH2AX-positive telomere-associated foci. It treats p21-high and p16-high cells as partly distinct populations, rather than establishing that senescent cells express both markers. Although it uses human adipose tissue for transplantation, the cited passages do not establish the full marker profile in human tissue or substantiate the entire listed SASP panel or MKI67 specifically. Page numbers were not available in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • Rests on an assumption: Marker expression observed in animal models can be extrapolated to human tissues.
  • May combine two claims.

    Findingcitation

    Human cardiac progenitor cells show increased CDKN2A, SA-β-gal, γH2AX foci, reduced BrdU incorporation, and SASP induction during ageing.

    “In humans, cardiac progenitor cells defined as KIT+PECAM1−PTPRC− (also known as c-kit+CD31−CD45−) showed increased levels of CDKN2A, SA-β-gal activity, γH2AX foci, reduced BrdU incorporation into DNA (S phase marker; reduced incorporation indicates cell cycle arrest) and induction of the SASP during ageing62.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [62] Lewis-McDougall, F. C. et al. Aged-senescent cells contribute to impaired heart regeneration. Aging Cell 18, e12931 (2019). source

      Section 2.1 (p. 4) reports age-related increases in p16INK4A (CDKN2A), SA-β-gal and γH2AX-positive human cardiac progenitor cells; the Discussion (p. 10) also reports a senescence-associated secretory phenotype. Figure 2 (p. 6) shows diminished proliferation in cells from aged hearts, but the BrdU result in section 2.3 (p. 8) concerns cells in hearts injected with progenitor cells, not BrdU incorporation by the human progenitor cells themselves. Thus, the specific reduced-BrdU-incorporation claim is unsupported. (LLM, conf=0.89)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Paracrine senescence is mediated by SASP, while juxtracrine senescence involves direct cell contact via NOTCH1-JAG1 signaling.

    “Two mechanisms of transmission have been described: paracrine senescence is mediated by the SASP24, whereas juxtracrine senescence, involving direct cell to cell contact, is mediated by NOTCH1–JAG1 signalling25,26.”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [24] Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978–990 (2013). source
    • cites [25] Teo, Y. V. et al. Notch signaling mediates secondary senescence. Cell Rep. 27, 997–1007.e5 (2019). source

      The Introduction says SASP can induce secondary senescence through paracrine signaling, and the Discussion identifies Notch signaling as cell-to-cell contact–mediated (juxtacrine). The paper does not establish the specific NOTCH1–JAG1 pairing attributed to it; its reported ligand finding concerns Jag2 instead. Our copy provides section labels but no page numbers. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [26] Evans S. A. et al. Single-cell transcriptomics reveals global markers of transcriptional diversity across different forms of cellular senescence. AgingBio 1, 1–13 (2023).

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Findingcitation

    Increased SA-β-gal activity, Bcl2, γH2AX, phosphorylated p38 MAPK, and downregulation of LMNB1 are additional features of age-associated or neurodegeneration-associated neuronal and glial cells.

    “Increased levels of SA-β-gal activity and expression of apoptosis (Bcl2) and DNA damage (γH2AX and phosphorylated p38 MAPK) regulators, and the downregulation of LMNB1, are additional characteristics of age-associated or neurodegeneration-associated neuronal and glial cells102,105–108.”
    Quote in the paperNot a substantial claim4 of 5 sources checked
    • cites [102] Ogrodnik, M. et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell 20, e13296 (2021). source

      The Results section reports an age-dependent increase in LMNB1-negative hippocampal neurons in mice, supporting the LMNB1 part of the claim. The passages do not establish increased SA-β-gal, Bcl2, γH2AX, or phosphorylated p38 MAPK in neuronal or glial cells, nor do they establish this marker pattern in neurodegeneration. Page numbers are unavailable in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [105] Matias, I. et al. Loss of lamin-B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus. Aging Cell 21, e13521 (2022). source

      The Results section reports increased SA-β-Gal activity in senescent astrocyte cultures, and the Discussion reports lamin-B1 loss in senescent astrocytes and aging hippocampal tissue (page numbers unavailable). These passages support those two features in astrocytes, but not the attributed increases in Bcl2, γH2AX, or phosphorylated p38 MAPK, nor the full extension of this marker list to neurons and neurodegeneration-associated cells. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [106] Chinta, S. J. et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease. Cell Rep. 22, 930–940 (2018). source

      The Results sections on Parkinsonian substantia nigra astrocytes and paraquat-induced senescence report reduced lamin B1 in astrocytes and increased SA-β-gal activity in paraquat-treated astrocytes. The paper reports 53BP1 foci as a DNA-damage marker, but the passages found do not establish increased Bcl2, γH2AX, or phosphorylated p38 MAPK as features of these cells, nor do they establish the listed features in neurons. Page numbers were not available in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [107] Musi, N. et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17, e12840 (2018). source

      The Results section reports elevated γ-H2ax in tauNFT mouse brains, and the Discussion describes loss of lamin B as associated with tau pathology. But the Results section on SA β-gal reports fewer positive cells than controls and says its activity did not correlate with other senescence markers or brain atrophy. Our copy does not establish increased Bcl2 or phosphorylated p38 MAPK, or these features specifically in glial cells. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [108] Dong, C. et al. ATM modulates subventricular zone neural stem cell maintenance and senescence through Notch signaling pathway. Stem Cell Res. 58, 102618 (2022). source
  • May combine two claims.

    Findingcitation

    In a mouse acute myeloid leukaemia model, qPCR of bone marrow cells showed upregulation of Cdkn2a, Cdkn1a, and SASP factors and downregulation of Lmnb1.

    “In a mouse model of acute myeloid leukaemia, qPCR of bone marrow cells showed upregulation of the senescence markers Cdkn2a, Cdkn1a and SASP factors, and downregulation of Lmnb1 (ref. 94).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [94] Abdul-Aziz, A. M. et al. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood 133, 446–456 (2019). source
  • May combine two claims.

    Findingcitation

    During normal ageing, mouse cardiomyocytes accumulate TAF, CDKN1a, CDKN2B, CDKN2a, SA-β-gal activity, SADS, and a pro-fibrotic SASP.

    “During normal ageing, mouse cardiomyocytes accumulate the following senescence-associated markers: TAF, cyclin-dependent kinase inhibitors (CDKN1a, CDKN2B (also known as p15INK4b) and CDKN2a), SA-β-gal activity, SADS and a pro-fibrotic SASP60.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [60] Anderson, R. et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 38, e100492 (2019). source
  • May combine two claims.

    Findingcitation

    Adipose tissue-derived mesenchymal stem cells from older human and mouse donors exhibit senescence properties and impaired regenerative potential.

    “Adipose tissue-derived mesenchymal stem cells from older donors (human and mouse) exhibit senescence properties and impaired regenerative potential123,124.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [123] Choudhery, M. S., Badowski, M., Muise, A., Pierce, J. & Harris, D. T. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J. Transl. Med. 12, 8 (2014). source

      The Conclusions report senescent features and reduced osteogenic and chondrogenic potential in adipose-derived MSCs from older donors. The Methods identify the donors as human; the Background’s mouse finding concerns bone marrow-derived MSCs, not adipose-derived MSCs. This source therefore does not support the claim’s mouse-adipose component. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
    • cites [124] Wang, B. et al. Transplanting cells from old but not young donors causes physical dysfunction in older recipients. Aging Cell 19, e13106 (2020). source
  • May combine two claims.

    Findingcitation

    In aged humans, needle biopsies of bone and bone marrow analysed by qPCR showed increased CDKN2A and CDKN1A, and SASP increased with age.

    “Needle biopsies containing tissue of the bone and bone marrow analysed by qPCR revealed increased levels of CDKN2A and CDKN1A, and the SASP increased with age93.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [93] Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920–1929 (2016). source

      The Results (page not provided) report that rt-qPCR of bone needle biopsies from older versus younger women found significantly higher p16Ink4a (CDKN2A) and p21 (CDKN1A) expression. Twelve SASP factors were also higher, but the 36-factor panel did not show a statistically significant increase as a group; the authors call the human SASP findings preliminary. The claim overstates that part as a general increase in the SASP. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    CDKN1A, CDKN2A and TAF are found in non-alcoholic fatty liver disease, and TAF are reported in livers from individuals with alcoholic liver disease.

    “Additionally, the expression of CDKN1A, CDKN2A and the presence of TAF has been found in the context of non-alcoholic fatty liver disease159,161, and TAF have been reported in livers from individuals with alcoholic liver disease162.”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [159] Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017). source

      The Results section, “Hepatocyte senescence correlates with severity of NAFLD” (page unavailable), reports TAF and p21—the protein encoded by CDKN1A—in biopsies from nine patients with NAFLD. It does not report CDKN2A expression in those patients. The alcoholic-liver-disease statement is attached to a different citation, so it is not assessed against this paper. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [161] Aravinthan, A. et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J. Hepatol. 58, 549–556 (2013). source
    • cites [162] Wilson, C. L. et al. NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat. Commun. 6, 6818 (2015). source
  • May combine two claims.

    Premisecitation

    Serpine1 overexpression causes podocyte detachment and apoptosis, resulting in glomerulosclerosis.

    “Serpine1 overexpression causes podocyte detachment and apoptosis, resulting in glomerulosclerosis140.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [140] Cohen, C. et al. Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1. EMBO Mol. Med. 13, e14146 (2021). source

      The Results sections report increased PAI-1 expression in aged mouse kidneys, PAI-1-dependent podocyte detachment and apoptosis in cell experiments, and protection from glomerulosclerosis after endothelial PAI-1 deletion in aged mice (page not available). These findings support the proposed pathway, but the paper does not show that experimentally overexpressing Serpine1 causes the entire sequence; its evidence concerns age-associated endothelial PAI-1 elevation and loss-of-function experiments. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Different animal models of kidney disease show increased SA-β-gal activity and overexpression of Cdkn2a, Cdkn1a, Trp53 and SASP components including SERPINE1, IL-1β, IL-6, TNF and MMP13.

    “Different animal models of kidney disease exhibit increased SA-β-gal activity and overexpression of Cdkn2a, Cdkn1a, Trp53 and SASP components, including SERPINE1, IL-1β, IL-6, TNF and MMP13 (refs. 140,148).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [140] Cohen, C. et al. Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1. EMBO Mol. Med. 13, e14146 (2021). source

      The Results sections on aging nephropathy and glomerular endothelial senescence (page unavailable) report SA-β-gal staining, increased p16 activity and p21-positive cells in mouse kidneys. They also report increased PAI-1 (encoded by SERPINE1), IL-1β, IL-6 and MMP13 in old versus young mice. The copy does not establish increased Trp53 or TNF, nor does it show that the full list is overexpressed across different kidney-disease models. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [148] Satriano, J. et al. Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes. Am. J. Physiol. Cell Physiol. 299, C374–C380 (2010). source

      The figure captions in the section labelled “4 Days” (page unavailable) report increased SA-β-gal activity, p16INK4a (Cdkn2a), p21 (Cdkn1a), and PAI-1 (SERPINE1) in streptozotocin-diabetic rats. This paper studies one animal model, not different models, and the cited passages do not establish overexpression of Trp53, IL-1β, IL-6, TNF, or MMP13. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingcitation

    Cdkn1ahigh and Cdkn2ahigh cells exist as two distinct cell populations in adipose tissue, indicating heterogeneity and complexity of senescent cell populations.

    “Importantly, Cdkn1ahigh and Cdkn2ahigh cells exist as two distinct cell populations122,125, indicating the heterogeneity and complexity of senescent cell populations in adipose tissue.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [122] Wang, L. et al. Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 34, 75–89.e8 (2022). source

      The Results section reports that p21-high (Cdkn1a-high) and p16-high (Cdkn2a-high) cells were distinguishable in mouse visceral adipose tissue after 10 months of high-fat feeding, despite some overlap. The Discussion calls them distinct populations, but explicitly limits that conclusion to at least the context of obesity; the citing sentence does not retain that qualifier. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [125] Wang, B. et al. An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo. Nat. Aging 1, 962–973 (2021). source
  • May combine two claims.

    Premisecitation

    Aged mouse hepatocytes show senescence-associated markers including SA-β-gal activity, TAF, karyomegaly, SADS, LINE-1 expression and SASP factors.

    “Studies on aged mouse hepatocytes have shown the presence of senescence-associated markers such as SA-β-gal activity157, TAF54,158, karyomegaly and SADS159, LINE-1 expression23 and expression of SASP factors141.”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [157] Wang, C. et al. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8, 311–323 (2009). source
    • cites [54] Hewitt, G. et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 3, 708 (2012). source
      Experimental — accuracy not yet measured
    • cites [158] Fumagalli, M. et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 14, 355–365 (2012). source

      The Results section on physiological ageing in primates reports telomere-associated DNA-damage foci in liver hepatocytes from old baboons, supporting the TAF portion of the citation. It does not establish TAF in aged mouse hepatocytes; its mouse experiment examined irradiated hippocampal neurons. The other listed markers have separate citations and are not attributed to this source. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Most human renal nephropathies are associated with accelerated cellular senescence, with CDKN2A being most overexpressed in TECs.

    “Most human renal nephropathies are associated with accelerated cellular senescence142,145,147,149,154,155, with CDKN2A being most overexpressed in TECs.”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [142] Prattichizzo, F. et al. Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages. Redox Biol. 15, 170–181 (2018). source

      The Results sections report increased senescence markers in kidneys of hyperglycaemic mice, and the References list a study of accelerated senescence in patients with type 2 diabetic nephropathy. That does not establish the claim about most human renal nephropathies. The paper also does not report that CDKN2A is most overexpressed in tubular epithelial cells; its kidney-cell results emphasize endothelial cells and macrophages. No page numbers are available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [145] Sis, B. et al. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 71, 218–226 (2007). source
    • cites [147] Verzola, D. et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 295, F1563–F1573 (2008). source
  • May combine two claims.

    Premisecitation

    TNSF8+PDCD1+CD44hiCD4+ T cells accumulate in adipose tissue in obesity and show senescence features, including increased SPP1, CDKN2A and CDKN1A and decreased SATB1, DUSP10 and EEF1A1.

    “TNSF8+PDCD1+CD44hiCD4+ (CD153+PDCD+CD44hiCD4+) T cells accumulate in adipose tissue in obesity and show senescence features, including increased expression of SPP1, CDKN2A and CDKN1A and decreased expression of SATB1, DUSP10 and EEF1A1128.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [128] Shirakawa, K. et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J. Clin. Invest. 126, 4626–4639 (2016). source

      The section on high-fat-diet-induced T-cell accumulation (page unavailable) reports that CD153+PD-1+CD44hiCD4+ cells accumulate in the visceral adipose tissue of obese mice and show senescence features. It reports increased Spp1, Cdkn1a and Cdkn2b—not the claimed CDKN2A—and decreased Satb1, Dusp10 and Eef1a1. The finding is specifically in mice and visceral adipose tissue. (LLM, conf=0.91)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    During ageing and obesity, SASP factors from senescent adipose cells upregulate CD38 in adipose immune cells, lowering NAD+ levels and worsening metabolic dysfunction and fitness.

    “Upon ageing and obesity, SASP factors from the senescent cells upregulate CD38 in adipose immune cells, thereby decreasing NAD+ levels, which results in increased metabolic dysfunction and a decline in overall fitness127.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [127] Chini, C. C. S. et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat. Metab. 2, 1284–1304 (2020). source

      The Results section, “Accumulation of CD38 in vivo can be induced by SASP” (page unavailable), reports that conditioned media from senescent pre-adipocytes increased macrophage CD38 and lowered NAD+ in mouse white adipose tissue. The Introduction links age-related NAD+ decline to metabolic dysfunction and reduced overall fitness. The paper does not establish this SASP–CD38 pathway in obesity or show that the pathway itself worsens metabolic function or fitness. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Glomerular endothelial cells and proximal tubular epithelial cells become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.

    “Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [140] Cohen, C. et al. Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1. EMBO Mol. Med. 13, e14146 (2021). source

      The Results sections on aging nephropathy and the time-course analysis show increased glomerular endothelial senescence in aged mice, more SA-βGal-positive glomeruli, increased p16 mRNA, and more p21-positive cells in both glomeruli and tubules. They do not identify the tubular cells as proximal epithelial cells or show increased SA-βGal staining and Cdkn2a expression specifically in those cells. No page numbers are available in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [141] Baker, D. J. et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature 530, 184–189 (2016). source

      The ‘Renal epithial cell senescence and glomerulosclerosis’ section (page unavailable) identifies SAβ-Gal-positive cells in proximal tubules, supporting the tubular epithelial-cell portion. It says those cells were not located in the glomeruli, so it does not support the glomerular endothelial-cell portion; it also does not report increased Cdkn2a expression in either specified kidney cell type. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    CyTOF analysis of young and aged mouse skeleton identified senescent cells in the bone microenvironment, principally CD24+ osteo-lineage cells and late osteoblasts/osteocytes, defined as CDKN2A+Ki67-BCL2+ and CDKN1A+Ki67-BCL2+, with increased other senescence markers, SASP factors and DNA damage markers.

    “Senescent cells in the bone microenvironment, which consisted principally of CD24+ osteo-lineage cells and late osteoblasts/osteocytes, were defined as CDKN2A+Ki67–BCL2+ and CDKN1A+ Ki67–BCL2+, and exhibited a significant increase in other senescence markers, SASP factors and DNA damage markers56.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [56] Doolittle, M. L. et al. Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton. Nat. Commun. 14, 4587 (2023). source
  • May combine two claims.

    Premisecitation

    Osteocytes have increased SADS with age, plus increased Cdkn2a, Cdkn1a, Trp53 and numerous SASP transcripts.

    “Osteocytes have increased SADS with age, in addition to an increase of Cdkn2a, Cdkn1a and Trp53 and numerous SASP transcripts93.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [93] Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920–1929 (2016). source
  • May combine two claims.

    Premisecitation

    Older individuals with asthma show increased Trp53 and Cdkn1a expression and TAF in airway smooth muscle cells.

    “Recent research has demonstrated increased expression of Trp53 and Cdkn1a, and the presence of TAF in the airway smooth muscle cells from older individuals with asthma174.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [174] Aghali, A. et al. Cellular senescence is increased in airway smooth muscle cells of elderly persons with asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 323, L558–L568 (2022). source
  • May combine two claims.

    Premisecitation

    The SenMayo gene panel was generated and validated in bone biopsies from two aged human cohorts.

    “The SenMayo gene panel (Box 3) was generated and validated in bone biopsies from two aged human cohorts84.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [84] Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022). source
  • May combine two claims.

    Premisecitation

    The senescent cells in the MAFA S64F model are characterized by expression of Cdkn1a, Ankrd1, Bcl2a1d, Ccl11, Cd68, Cxcl12 and Icam1, SA-β-gal activity, decreased Lmnb1 and increased γH2AX.

    “These cells are characterized by expression of Cdkn1a, Ankrd1, Bcl2a1d, Ccl11, Cd68, Cxcl12 and Icam1, SA-β-gal activity, decreased Lmnb1 expression and increased γH2AX185.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [185] Walker, E. M. et al. Sex-biased islet β cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males. Cell Rep. 37, 109813 (2021). source

      The Results section ('Only male MafAS64F/+ islets express markers of accelerated cellular senescence and aging'; page unavailable) reports increased p21 and γH2AX staining, increased SA-β-gal activity, and decreased LaminB1 in male mutant islets. It also reports increased aging- and senescence-related gene expression, but our copy does not identify Ankrd1, Bcl2a1d, Ccl11, Cd68, Cxcl12, or Icam1 as expressed markers. The specific gene list is therefore not fully supported by the available text. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Interpretationcitation

    Focal radiation therapy-induced bone loss can be alleviated by targeting senescent cells expressing Cdkn1a but not Cdkn2a, suggesting functional heterogeneity between senescent cell subtypes.

    “Focal radiation therapy-induced bone loss can be alleviated by targeting senescent cells expressing Cdkn1a, but not Cdkn2a (ref. 203), suggesting the existence of functional heterogeneity between senescent cell subtypes.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [203] Chandra, A. et al. Targeted clearance of p21- but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity. Aging Cell 21, e13602 (2022). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    TGFβ1-IL-11-MEK-ERK signalling mediates senescence-associated pulmonary fibrosis in mice.

    “TGFβ1 has been implicated in mediating cellular senescence in the lung, as TGFβ1–IL-11–MEK–ERK signalling mediates senescence-associated pulmonary fibrosis in mice171.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [171] Chen, H. et al. TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency. Exp. Mol. Med. 52, 130–151 (2020). source
  • May combine two claims.

    Premisecitation

    Whether osteoclasts undergo senescence remains unclear, although elimination of CDKN2A-expressing osteoclast progenitors did not attenuate age-related bone loss in mice.

    “Whether osteoclasts also undergo senescence remains unclear, although elimination of CDKN2A-expressing osteoclast progenitors did not attenuate age-related bone loss in mice198.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [198] Kim, H.-N. et al. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice. Aging Cell 18, e12923 (2019). source
  • May combine two claims.

    Premisecitation

    Osteoblast progenitors and osteoblasts show a significant increase of Cdkn2a and a limited number of SASP factors.

    “Osteoblast progenitors and osteoblasts exhibit a significant increase of Cdkn2a, in addition to an increase of a limited number of SASP factors93.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [93] Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920–1929 (2016). source
  • May combine two claims.

    Premisecitation

    Proteomics analysis of senescent and non-senescent mouse and human pancreatic islet cells confirmed SASP protein secretion and led to description of a unique SASP in β-cells.

    “The secretion of SASP protein factors has been confirmed through proteomics analysis of senescent (SA-β-gal+) and non-senescent (SA-β-gal–) mouse and human pancreatic islet cells183, leading to the description of a unique SASP in β-cells.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [183] Midha, A. et al. Unique human and mouse β-cell senescence-associated secretory phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes 70, 1098–1116 (2021). source
  • May combine two claims.

    Premisecitation

    Following fracture in mice, fracture callus cells show an initial increase in Cdkn1a mRNA, followed by Cdkn2a, accompanied by a SASP including interleukins, NF-κB-downstream factors and TGFβ1.

    “Following fracture in mice, cells from the fracture callus exhibit an initial increase in Cdkn1a mRNA expression, followed by Cdkn2a and accompanied by a SASP consisting of numerous interleukins, NF-κB-downstream factors and, specifically, TGFβ1 expression200,201.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [200] Saul, D. et al. Modulation of fracture healing by the transient accumulation of senescent cells. eLife 10, e69958 (2021). source

      The Results sections on murine fracture healing and callus SASP expression report an early Cdkn1a mRNA increase followed by a progressive Cdkn2a increase, alongside changes in interleukins and Tgfb1. They report increased expression of Nfkb1 itself, but do not identify the measured factors as downstream of NF-κB; that specific characterization is unsupported. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [201] Liu, J. et al. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. J. Clin. Invest. 132, e148073 (2022). source

      The Results section on senescent cells in fracture callus reports that p21 (Cdkn1a) and p16 (Cdkn2a) both increased after fracture and both peaked on day 10; it does not establish that one rose before the other. The Results section on SASP factors reports elevated Il1a and Tgfb1 in aged callus, supporting that portion of the claim, but it does not identify the measured factors as NF-κB downstream factors or establish numerous interleukins. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    This skin senescence expression pattern correlates with lower MKI67 expression and only slightly with telomere length reduction.

    “This expression pattern correlates with lower MKI67 expression and only slightly with telomere length reduction210.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [210] Rube, C. E. et al. Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis. NPJ Aging Mech. Dis. 7, 7 (2021). source
  • May combine two claims.

    Premisecitation

    In the mouse skin chemical carcinogenesis model, TPA tumour promotion features an increase in SA-β-gal+ keratinocytes with high CDKN2A, increased Mmp3, Mmp9 and Cxcl10 and downregulation of Lmnb1.

    “In the mouse skin chemical carcinogenesis model, tumour promotion with the phorbol ester TPA features an increase in SA-β-gal+ keratinocytes with high CDKN2A levels, accompanied by increased levels of Mmp3, Mmp9 and Cxcl10 and downregulation of Lmnb1 (ref. 223).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [223] Alimirah, F. et al. Cellular senescence promotes skin carcinogenesis through p38MAPK and p44/42MAPK signaling. Cancer Res. 80, 3606–3619 (2020). source

      The Results section, “TPA induces senescence and a SASP in human keratinocytes and mouse skin” (page unavailable), reports increased SA-β-gal-positive cells and elevated p16, Mmp3, Mmp9 and Cxcl10 mRNAs in TPA-treated mouse skin. It does not identify the SA-β-gal-positive mouse cells specifically as keratinocytes. Reduced Lamin B1 is reported for TPA-treated human keratinocytes, not mouse skin. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Extravillous trophoblasts display nuclear enlargement, and syncytiotrophoblasts show senescence and ageing characteristics such as increased syncytial knots, fibrinoid deposition and cytoskeleton reorganization.

    “Furthermore, extravillous trophoblasts display nuclear enlargement247, and syncytiotrophoblasts exhibit characteristics of senescence and ageing, such as increased syncytial knots and fibrinoid deposition254 and reorganization of their cytoskeleton255.”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [247] Velicky, P. et al. Genome amplification and cellular senescence are hallmarks of human placenta development. PLoS Genet. 14, e1007698 (2018). source
    • cites [254] Wang, Y. et al. SIRT1 regulates trophoblast senescence in premature placental aging in preeclampsia. Placenta 122, 56–65 (2022). source
    • cites [255] Ishikawa, A. et al. Cell fusion mediates dramatic alterations in the actin cytoskeleton, focal adhesions, and E-cadherin in trophoblastic cells. Cytoskeleton 71, 241–256 (2014). source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The ovary ages earlier than other organs in the human body, with reproductive function declining in the mid-thirties and ceasing at menopause.

    “The ovary ages earlier than other organs in the human body, as reproductive function begins declining in women in their midthirties and ceases completely at the time of menopause.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [232] Lemaitre, J. F. & Gaillard, J. M. Reproductive senescence: new perspectives in the wild. Biol. Rev. Camb. Philos. Soc. 92, 2182–2199 (2017). source
    • cites [233] Dong, L., Teh, D. B. L., Kennedy, B. K. & Huang, Z. Unraveling female reproductive senescence to enhance healthy longevity. Cell Res. 33, 11–29 (2023). source
  • May combine two claims.

    Premisecitation

    In fibroblasts, keratinocytes and melanocytes in vitro, the classical SASP typically includes IL-6, IL-1α, IL-1β, MMP1, MMP3, MMP9 and TNF, whereas high chemerin levels are found in the SASP of dermal fibroblasts in aged skin.

    “In fibroblasts, keratinocytes and melanocytes in vitro, the classical SASP typically includes IL-6, IL-1α, IL-1β, MMP1, MMP3, MMP9 and TNF211, whereas high levels of chemerin are found in the SASP of dermal fibroblasts in aged skin215.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [211] Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853–2868 (2008). source

      The ‘SASPs of Human Epithelial Cells’ passage reports overlapping SASPs in cultured fibroblasts and prostate epithelial cells, including IL-6, but says IL-1α was specific to one of those cell types. The cited paper does not establish the listed factors as a typical SASP across fibroblasts, keratinocytes and melanocytes; it studies prostate epithelial cells rather than the latter two. The chemerin clause has a different citation (215) and is not judged here. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [215] Farsam, V. et al. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget 7, 83554–83569 (2016). source
  • May combine two claims.

    Premisecitation

    Despite high variability in the SASP of intrinsically aged human fibroblasts in vivo, there is an association between GDF15, TNF, SPP1, TNFRSF1A, FAS, CCL3, IL-15 and activin A expression and age-related disease outcomes.

    “Despite high variability (for example, the SASP of intrinsically aged human fibroblasts in vivo includes 27 distinct proteins212), there is an association between GDF15, TNF, SPP1, TNFRSF1A, FAS, CCL3, IL-15 and activin A expression and age-related disease outcomes214.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [212] Waldera Lupa, D. M. et al. Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. J. Invest. Dermatol. 135, 1954–1968 (2015). source
    • cites [214] Schafer, M. J. et al. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight 5, e133668 (2020). source
  • May combine two claims.

    Premisecitation

    TNFRSF11A expression increases during ageing, leading to DNA damage and senescence through Cdkn2a.

    “The expression of TNFRSF11A increases during ageing228, leading to DNA damage and senescence through Cdkn2a (ref. 229).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [228] Pellegrini, P. et al. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. Stem Cell 31, 1954–1965 (2013). source
    • cites [229] Benitez, S. et al. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness. Dev. Cell 56, 1727–1741.e7 (2021). source
  • May combine two claims.

    Premisecitation

    In sun-protected skin, melanocytes show the highest rate of senescence, identified by CDKN2A expression, increased TAF and loss of nuclear HMGB1.

    “In sun-protected skin, melanocytes showed the highest rate of senescence, as identified by the expression of CDKN2A and increased number of TAF, and loss of nuclear HMGB1 (ref. 213).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [213] Victorelli, S. et al. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. EMBO J. 38, e101982 (2019). source
  • May combine two claims.

    Interpretationcitation

    Several CCL and CXCL genes are expressed in immune cells of the postmenopausal human ovary and may potentially reverse some detrimental effects of senescence.

    “Moreover, several CCL and CXCL genes are expressed in immune cells of the postmenopausal human ovary, potentially reversing some of the detrimental effects of senescence246.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [246] Lengyel, E. et al. A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Rep. 41, 111838 (2022). source
  • May combine two claims.

    Premisecitation

    Genotoxic chemotherapeutics cisplatin and doxorubicin accelerate reproductive ageing and result in increased SA-β-gal, CDKN2A and CDKN1A expression.

    “Apart from physiological ageing, treatments that accelerate reproductive ageing through genotoxic agents, such as the chemotherapeutics cisplatin242 and doxorubicin243, result in increased SA-β-gal242,243, CDKN2A (refs. 242,243) and CDKN1A (refs. 242,243) expression.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [242] Du, D. et al. Senotherapy protects against cisplatin-induced ovarian injury by removing senescent cells and alleviating DNA damage. Oxid. Med. Cell. Longev. 2022, 9144644 (2022).

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [243] Gao, Y. et al. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics. GeroScience 45, 1775–1790 (2023). source
  • May combine two claims.

    Premisecitation

    The BRAF oncogenic mutation found in more than half of malignant cutaneous melanomas is also common in non-malignant nevi, where it causes oncogene-induced senescence with high CDKN2A and SA-β-gal expression.

    “Additionally, the BRAF oncogenic mutation found in more than half of all malignant cutaneous melanomas is commonly found also in non-malignant nevi, where it causes oncogene-induced senescence exemplified by high levels of CDKN2A and SA-β-gal expression225–227.”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [225] Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720–724 (2005). source

      The Abstract and main text report that BRAF V600E is frequent in benign naevi and that sustained expression induces senescence-like arrest with SA-β-Gal activity and increased p16INK4a, the CDKN2A protein. However, the paper does not establish the claimed ‘more than half’ frequency in cutaneous melanomas, and it describes p16INK4a expression in naevi as mosaic rather than uniformly high. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [226] Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19–20 (2003). source
    • cites [227] Hugdahl, E., Kalvenes, M. B., Puntervoll, H. E., Ladstein, R. G. & Akslen, L. A. BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival. Br. J. Cancer 114, 801–808 (2016). source

      The introductory passage following the Abstract’s Conclusions says that nearly 50% of primary and metastatic melanomas harbour BRAF mutations, supporting their prevalence but not the claim’s ‘more than half’ figure. The paper does not address BRAF mutations in non-malignant nevi or senescence marked by CDKN2A and SA-β-gal expression. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Skin senescence is identified by SA-β-gal, α-fucosidase, CDKN2A, CDKN1A and lipofuscin in epidermis and dermis, and by H2AJ and γH2AX in human epidermis, especially stratum spinosum.

    “Senescence in the skin is identified by expression of SA-β-gal, α-fucosidase, CDKN2A, CDKN1A and lipofuscin in both the epidermis and the dermis207,208, and of the histone variant H2AJ and γH2AX in human epidermis, especially in the stratum spinosum209.”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [207] Hudgins, A. D. et al. Age- and tissue-specific expression of senescence biomarkers in mice. Front. Genet. 9, 59 (2018). source

      The Results identify Cdkn2a and Cdkn1a as classical senescence markers, but the mouse tissues studied were hypothalamus, heart, liver, and kidney—not epidermis or dermis. The cited paper does not establish the claimed skin-layer expression of those markers or address α-fucosidase and lipofuscin. The H2AJ and γH2AX clause is attached to a different citation (209) and is not judged here. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [208] Dimri, G. P. A biomarker that identifies senescenet human cells in culture and aging skin in vitro. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995). source
    • cites [209] Contrepois, K. et al. Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression. Nat. Commun. 8, 14995 (2017). source

      The Results section ('H2A.J is a biomarker of some senescent stem and skin cells'; page unavailable) reports that H2A.J-positive cells increase in aging human epidermis and suggests H2A.J as a biomarker of some senescent skin cells. It reports 53BP1 foci—not γH2AX—in human epidermis and does not identify the stratum spinosum as a particular site. The earlier markers are attached to citations 207 and 208, so they are not assessed against this source. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    The ovary exhibits age-dependent inflammation and fibrosis, but whether these are associated with senescence has not been conclusively established.

    “Additionally, the ovary exhibits age-dependent inflammation and fibrosis234–237; however, whether these are associated with senescence has not been conclusively established.”
    Quote in the paperNot a substantial claim4 of 4 sources checked
    • cites [234] Briley, S. M. et al. Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction 152, 245–260 (2016). source
    • cites [235] Lliberos, C. et al. Evaluation of inflammation and follicle depletion during ovarian ageing in mice. Sci. Rep. 11, 278 (2021). source

      The Discussion reports increased inflammatory markers in ageing mouse ovaries, and the Introduction cites an earlier study finding more stromal fibrosis in older mice. But this paper’s own Results (“Fibrosis does not change in the ageing mouse ovary”) found no significant change in fibrosis from 2 to 18 months, so it does not establish age-dependent fibrosis. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [236] Amargant, F. et al. Ovarian stiffness increases with age in the mammalian ovary and depends on collagen and hyaluronan matrices. Aging Cell 19, e13259 (2020). source
    • cites [237] Zhang, Z., Schlamp, F., Huang, L., Clark, H. & Brayboy, L. Inflammaging is associated with shifted macrophage ontogeny and polarization in the aging mouse ovary. Reproduction 159, 325–337 (2020). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Several senescence markers increase in the ageing mouse colon in homogenized tissue.

    “Several senescence markers have been reported to increase in the ageing mouse colon in homogenized tissue141.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [141] Baker, D. J. et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature 530, 184–189 (2016). source
  • May combine two claims.

    Premisecitation

    Mitochondria of syncytiotrophoblasts undergo morphological and functional changes, with decreased size and ATP production, leading to increased ROS production to adapt to changing oxygen tension in the placenta.

    “Moreover, mitochondria of syncytiotrophoblasts undergo morphological and functional changes, characterized by decreased size and diminished ATP production, leading to increased ROS production to adapt to changing oxygen tension in the placenta248,256.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [248] Cindrova-Davies, T., Fogarty, N. M. E., Jones, C. J. P., Kingdom, J. & Burton, G. J. Evidence of oxidative stress-induced senescence in mature, post-mature and pathological human placentas. Placenta 68, 15–22 (2018). source

      The Results and Discussion describe oxidative stress and senescence in syncytiotrophoblasts and placental explants after hypoxia-reoxygenation, but do not address the claimed mitochondrial changes. Searches for mitochondrial size, ATP production, ROS production, and adaptation to oxygen tension found no passage supporting that mechanism. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
    • cites [256] Bartho, L. A., Fisher, J. J., Cuffe, J. S. M. & Perkins, A. V. Mitochondrial transformations in the aging human placenta. Am. J. Physiol. Endocrinol. Metab. 319, E981–E994 (2020). source
  • May combine two claims.

    Premisecitation

    Telomeres from fetal growth restriction placentas are shorter and express higher CDKN2A and CDKN1A protein and EEF1A1 RNA compared with placentas from normal growth fetuses.

    “Telomeres from fetal growth restriction placentas are shorter and express higher levels of CDKN2A and CDKN1A protein and EEF1A1 RNA compared with placentas from normal growth fetuses265.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [265] Davy, P., Nagata, M., Bullard, P., Fogelson, N. S. & Allsopp, R. Fetal growth restriction is associated with accelerated telomere shortening and increased expression of cell senescence markers in the placenta. Placenta 30, 539–542 (2009). source

      The Results and discussion section reports shorter telomeres and higher expression of p16, p21, and EF-1α in FGR placentas than in controls. But it measured expression of all three markers by RT-PCR; it does not establish higher CDKN2A or CDKN1A protein levels. Page numbers are unavailable in our copy. (LLM, conf=0.91)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Trophoblast senescence is physiological, progresses with gestation and peaks at term; senescence is also described in maternal decidual cells and fetoplacental membranes, where it promotes parturition and placental detachment at term.

    “In addition to trophoblast senescence, which is a physiological phenomenon that progresses with gestation and peaks at term, senescence is also extensively described in maternal decidual cells and fetoplacental membranes, where it has a pivotal role in the promotion of parturition and detachment of the placenta from the uterus at term257–262.”
    Quote in the paperNot a substantial claim4 of 6 sources checked
    • cites [257] Menon, R. Human fetal membranes at term: dead tissue or signalers of parturition? Placenta 44, 1–5 (2016). source

      The sections on fetal membrane structure and biologic aging describe physiological membrane senescence during pregnancy and at term; the latter says signals from senescent membranes could trigger parturition. The copy does not establish the claimed gestational trajectory of trophoblast senescence, senescence in maternal decidual cells, or a role in placental detachment. It also presents the membrane contribution to labor as possible, rather than pivotal. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [258] Bonney, E. A. et al. Differential senescence in feto-maternal tissues during mouse pregnancy. Placenta 43, 26–34 (2016). source

      The Discussion (page not provided) reports that fetal-membrane senescence progresses through mouse gestation, while placental and decidual senescence is minimal and detectable only near its end. The Conclusions say fetal-membrane senescence may contribute to parturition at term. The paper does not establish progressive senescence specifically in trophoblasts or a role for senescence in placental detachment, and the claim states the parturition role more definitively than the source does. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [259] Cox, L. S. & Redman, C. The role of cellular senescence in ageing of the placenta. Placenta 52, 139–145 (2017). source
    • cites [260] Wijaya, J. C., Khanabdali, R., Georgiou, H. M. & Kalionis, B. Ageing in human parturition: impetus of the gestation clock in the deciduadagger. Biol. Reprod. 103, 695–710 (2020). source
    • cites [261] Menon, R. et al. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging 8, 216–230 (2016). source

      The Results section (page unavailable) reports increased senescence markers in fetal amnion and chorion membranes at term labor, and the Introduction proposes that membrane-cell senescence may promote parturition. The paper does not establish senescence in trophoblasts or maternal decidual cells, a gestation-long progression peaking at term, or a role in placental detachment. It also treats promotion of labor as a hypothesis rather than a proven causal role. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [262] Rajagopalan, S. & Long, E. O. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl Acad. Sci. USA 109, 20596–20601 (2012). source

      The section on CD158d activation reports a senescence signature in decidual NK cells during weeks 6–12 of pregnancy, and the paper proposes a reproductive role through vascular remodeling in early pregnancy. It does not establish senescence of trophoblasts or fetoplacental membranes, progression or a peak at term, or a role in parturition or placental detachment. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Findingnone given

    The Biomarkers Working Group observed that the literature tends to oversimplify cell-state annotation, worsened by no universally accepted definition of cellular senescence.

    “The Biomarkers Working Group within SenNet has observed a recurring issue within the scientific literature regarding cellular senescence in various tissues in the context of ageing and age-related conditions, namely a tendency towards oversimplification of cell-state annotation, exacerbated by the absence of a universally accepted definition of cellular senescence.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    A considerable portion of the literature relies on analyses of homogenized tissue samples, ignoring unique attributes of distinct cell types.

    “Importantly, a considerable portion of the literature heavily relies on analyses of homogenized tissue samples, which disregards the unique attributes of distinct cell types.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Findingown data

    The database contains information from 224 peer-reviewed papers and 328 markers across 14 mouse and human tissues plus circulating markers.

    “The database contains information from 224 peer-reviewed papers and 328 markers, covering a total of 14 mouse and human tissues, along with circulating markers.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The set of 224 papers and 328 markers in their database is sufficiently comprehensive and representative to support tissue-specific marker recommendations.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Table 1 includes senescence markers documented in the database in three or more tissues.

    “Table 1 features senescence markers documented in our database in three or more tissues.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    These markers represent six of the nine senescence hallmarks, with SASP most represented.

    “Collectively, these markers represent six of the nine senescence hallmarks, with the SASP being most represented.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    H2AX is the most utilized DDR marker across tissues, followed by telomere length and TAF.

    “H2AX is the most utilized marker for assessing the DDR across tissues, followed by telomere length and TAF.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Loss of LMNB1 and nuclear HMGB1 have been documented in 5 and 7 tissues, respectively.

    “nuclear changes evidenced by the loss of LMNB1 and nuclear HMGB1 have been documented in 5 and 7 tissues, respectively.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given

    In tissues, senescent cells are relatively rare and difficult to characterize.

    “By contrast, in tissues, these cells are relatively rare and difficult to characterize”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    In tissue culture studies, each cell in the culture is driven to irreversible cell cycle arrest.

    “Much of our understanding of senescent cell biology still originates from tissue culture studies, where each cell in the culture is driven to an irreversible cell cycle arrest.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    Multiple hallmarks must be present to identify senescent cells.

    “Therefore, the presence of multiple hallmarks is required to identify senescent cells.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The presence of multiple senescence hallmarks in the same cell is sufficient to identify a senescent cell.
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    The review selected publications that evaluated multiple senescence-associated markers.

    “Additionally, our selection criteria focused on publications that evaluated multiple senescence-associated markers.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    Fully differentiated postmitotic cells can also acquire a senescence phenotype.

    “it is now established that fully differentiated, postmitotic cells can also acquire a senescence phenotype”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    No specific marker of cellular senescence exists; almost all proposed markers can be absent from senescent cells in some contexts or present in non-senescent cells.

    “A key challenge is the lack of a specific marker of cellular senescence, as virtually all markers that have been proposed can be absent from senescent cells in specific contexts (for example, cell types, senescence type), or they can be present in non-senescent cells.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    Because SASP features overlap with immune cell features, markers are needed to distinguish activated resident immune cells from bona fide senescent cells.

    “As features of the SASP overlap with those of immune cells, it is imperative to identify marker(s) that can distinguish between activated resident immune cells and bona fide senescent cells.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The heterogeneity of senescence in the ageing mouse and human brain requires cell type-specific and region-specific characterization.

    “Importantly, the complex heterogeneity of senescence in the ageing mouse and human brain warrants cell type-specific and region-specific characterization.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In human ageing kidneys, CDKN2A, CDKN1B, CDK4, MMP1 and HSPA5 mRNA increase in the cortex, and nuclear CDKN2A staining is predominantly in distal tubules and collecting ducts, but also in glomerular parietal epithelium and podocytes.

    “CDKN2A, CDKN1B, CDK4, MMP1 and HSPA5 mRNA levels increase in the cortex and nuclear staining of CDKN2A is observed predominantly in distal tubules and collecting ducts, but also in glomerular parietal epithelium and podocytes151.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [151] Melk, A. et al. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65, 510–520 (2004). source
  • May combine two claims.

    Premisecitation

    Telomeres are shorter in the kidney cortex but not in the medulla.

    “Telomeres are shorter in the cortex but not in the medulla153.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [153] Melk, A. et al. Telomere shortening in kidneys with age. J. Am. Soc. Nephrol. 11, 444–453 (2000). source
  • May combine two claims.

    Premisecitation

    CDKN2A protein expression in cortical interstitial cells and TECs correlates with age, whereas CDKN1B protein expression correlates with age only in cortical tubular cells.

    “CDKN2A protein expression in cortical interstitial cells and TECs correlates with age; by contrast, expression of CDKN1B protein correlates with age only in cortical tubular cells152.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [152] Chkhotua, A. B. et al. Increased expression of p16INK4a and p27Kip1 cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am. J. Kidney Dis. 41, 1303–1313 (2003). source
  • May combine two claims.

    Premisecitation

    Nuclear CDKN2A level increases in glomerular and interstitial cells in glomerular disease and in tubules and podocytes in diabetic nephropathy.

    “Furthermore, the nuclear CDKN2A level increases in glomerular and interstitial cells in individuals with glomerular disease145, and in tubules and podocytes in individuals with diabetic nephropathy147.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [145] Sis, B. et al. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 71, 218–226 (2007). source
    • cites [147] Verzola, D. et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 295, F1563–F1573 (2008). source
  • May combine two claims.

    Premisecitation

    In post-mortem pancreas of 140 individuals without pancreatic disease, 114 (81%) had ductal lesions such as mucous cell hyperplasia typically associated with KRAS activating mutations, and these lesions increase after age 40.

    “In a study of the post-mortem pancreas of 140 individuals without pancreatic disease, 114 (81%) exhibited ductal lesions such as mucous cell hyperplasia, typically associated with KRAS activating mutations; the ductal lesions show an increasing trend after the age of 40 years195.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [195] Luttges, J. et al. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch. 435, 461–468 (1999). source
  • May combine two claims.

    Interpretationcitation

    Senescence is induced in early neoplastic stages and may have a role in preventing progression of malignancy.

    “These findings suggest that senescence is induced in early neoplastic stages and may have a role in preventing the progression of malignancy.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [197] Miyasaka, Y. et al. Senescence in intraductal papillary mucinous neoplasm of the pancreas. Hum. Pathol. 42, 2010–2017 (2011). source
  • May combine two claims.

    Premisenone given

    Developmental senescence is a programmed transient cellular senescence with a crucial role in mammalian embryonic development, occurring in both embryo and placenta.

    “Developmental senescence is a programmed transient cellular senescence that has a crucial role in mammalian embryonic development, occurring not only in the embryo but also in the placenta.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given

    The primary objective of this work was to establish a foundation for informed development of spatial mapping panels based on existing evidence of tissue senescence markers.

    “Our primary objective here was to establish a foundation for the informed development of spatial mapping panels based on the existing evidence of senescence markers in tissues.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    The database associated with this Expert Recommendation will be a dynamic document regularly updated by SenNet with new findings from within the consortium and beyond.

    “The database associated with this Expert Recommendation will serve as a dynamic document that SenNet will regularly update, incorporating novel findings from within the consortium and beyond.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    SenNet results and broader spatial mapping work will considerably advance understanding of senescence diversity across cell types and its functional implications in ageing and disease.

    “We anticipate that the results generated by SenNet, as well as by the broader cellular senescence research community using spatial mapping techniques, will considerably advance our comprehension of the diversity of senescence in various cell types and its functional implications in ageing and disease.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Highly specific syncytiotrophoblast genes are induced in physiologically aged fibroblasts and during replicative or stress-induced senescence in non-trophoblast cell lineages.

    “Recently, highly specific syncytiotrophoblast genes were identified to be induced in physiologically aged fibroblasts, as well as during replicative senescence or stress-induced cellular senescence in non-trophoblast cell lineages263.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [263] Liu, Z. et al. Large-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging. Dev. Cell 57, 1347–1368.e12 (2022). source
  • Classified as probably not a substantial claim.

    Premisenone given

    SenNet's multimodal efforts are designed to identify novel and specific senescence markers that can be differentiated from other cellular changes during ageing.

    “The multimodal efforts of SenNet are designed to pinpoint novel and specific markers of senescence, enabling us to differentiate them from other types of cellular change that may occur during ageing.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    This Expert Recommendation focused its discussion on senescence markers applied to identifying senescent cells in individual tissues.

    “Specifically, we have focused our discussion on senescence markers applied to the identification of senescent cells in individual tissues.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Machine learning and artificial intelligence techniques are under development to distinguish senescent from non-senescent cells based on morphological differences.

    “Furthermore, innovative machine learning and artificial intelligence techniques are under development to distinguish senescent from non-senescent cells based on their morphological differences (Box 3).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisereasoning

    High-content and high-throughput single-cell and spatial omics technologies accelerate discovery of senescence biomarkers needed for progress in ageing and disease research.

    “To achieve this goal, high-content and high-throughput single-cell and spatial omics technologies are deployed, which accelerate the discovery of crucial senescence biomarkers required for progress in the study of ageing and disease (Box 5).”
    Quote in the paperSubstantial claim
78 of 78
  • The paper relies on this without support.

    The set of 224 papers and 328 markers in their database is sufficiently comprehensive and representative to support tissue-specific marker recommendations.

    “The database contains information from 224 peer-reviewed papers and 328 markers, covering a total of 14 mouse and human tissues, along with circulating markers.”
  • The paper relies on this without support.

    The presence of multiple senescence hallmarks in the same cell is sufficient to identify a senescent cell.

    “Our recommendation is to require the presence of multiple hallmarks of senescence in the same cell, as described in Box 2.”
  • The paper relies on this without support.

    Marker expression observed in animal models can be extrapolated to human tissues.

    “in 14 tissues in mice and humans”
  • The paper relies on this without support.

    The senescence markers reported in the cited studies are valid indicators of cellular senescence in the tissues discussed.

    “Based on information from published human and mouse studies, we have outlined the current knowledge about senescence markers that are specific to various tissues.”
  • The paper relies on this without support.

    Findings about senescence markers in mouse tissues can inform the identification of senescent cells in the corresponding human tissues.

    “Senescence is observed in several human and mouse kidney cell types during healthy ageing and nephropathy.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Low-grade lesions are described as preceding the neoplasm they belong to

    Minor

    The study's low-grade dysplasia cases are presented as intraductal papillary mucinous neoplasms. The next sentence describes a decline in the same markers during the transition to intraductal papillary mucinous neoplasm, even though those lesions are already cases of it.

1 of 1

Cites

Flagged first, then by citations

2 of the 309 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., Schilling, B., Carver, C. M., Aguayo-Mazzucato, C., Baker, D. J., Bernlohr, D. A., Jurk, D., Mangarova, D. B., Quardokus, E. M., Enninga, E. A. L., Schmidt, E. L., Chen, F., Duncan, F. E., Cambuli, F., Kaur, G., Kuchel, G. A., Lee, G., Daldrup-Link, H. E., Martini, H., Phatnani, H., Al-Naggar, I. M., Rahman, I., Nie, J., Passos, J. F., Silverstein, J. C., Campisi, J., Wang, J., Iwasaki, K., Barbosa, K., Metis, K., Nernekli, K., Niedernhofer, L. J., Ding, L., Wang, L., Adams, L. C., Ruiyang, L., Doolittle, M. L., Teneche, M. G., Schafer, M. J., Xu, M., Hajipour, M., Boroumand, M., Basisty, N., Sloan, N., Slavov, N., Kuksenko, O., Robson, P., Gomez, P. T., Vasilikos, P., Adams, P. D., Carapeto, P., Zhu, Q., Ramasamy, R., Perez-Lorenzo, R., Fan, R., Dong, R., Montgomery, R. R., Shaikh, S., Vickovic, S., Yin, S., Kang, S., Suvakov, S., Khosla, S., Garovic, V. D., Menon, V., Xu, Y., Song, Y., Suh, Y., Dou, Z., & Neretti, N.
Affiliations
  • Stanford Medicine (US)
  • Columbia University (US)
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • Washington University in St. Louis (US)
  • National Institute on Aging (US)
  • University of Minnesota (US)
  • Brown University (US)
  • Buck Institute for Research on Aging (US)
  • Mayo Clinic (US)
  • Indiana University Bloomington (US)
  • Northwestern University (US)
  • New York Genome Center (US)
  • University of Rochester Medicine (US)
  • UConn Health (US)
  • Columbia University Irving Medical Center (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Pittsburgh (US)
  • Joslin Diabetes Center (US)
  • Northeastern University (US)
  • University of Connecticut (US)
  • University of California San Diego (US)
  • The Jackson Laboratory for Genomic Medicine (US)
  • Yale University (US)
  • University of Washington (US)
  • Harvard University (US)
Corresponding author
Neretti, Nicola
Venue
Nature Reviews Molecular Cell Biology
Published
2024-06-03
Volume
25
Issue
12
Pages
1001-1023
ISSN
  • 1471-0072 (ISSN-L)
  • 1471-0080
OpenAlex
W4399285708
Cited by
408
References
309
Citations by year
2026: 184 · 2025: 186 · 2024: 37 · 2023: 1
FWCI
23.12
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Molecular Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders
  • National Institutes of Health (5ug3ca275686-02, AG062413)
  • National Institute on Aging (F31AG072748, R01AG069819, R01AG068182, U01AG060906, R01AG050582, R01AG068048, P01AG017242, R33AG061456, T32AG041688, U54AG075934, R01AG076642, U54AG075941, U54AG075932, R01AG082708, U54AG079779, P30AG067988, U54AG079754, U54AG076041, P01AG062413, U54AG076040, R01AG076515, U54AG079758, U54AG079753, U54AG079759, U54AG075931)
  • National Heart, Lung, and Blood Institute (R01HL147575, R01HL147290)
  • National Institute of Mental Health (T32MH126036)
  • National Human Genome Research Institute (RM1HG011014)
  • National Cancer Institute (UG3CA268105, UG3CA268202, UG3CA268112, UH3CA268103, UG3CA268117, UG3CA275669, UG3CA268103, UG3CA268096, P30CA015083, UH3CA275686, U24CA268108, UG3 CA275686)
  • National Institute of General Medical Sciences (T32GM136566)
  • National Institute of Allergy and Infectious Diseases (U19AI089992)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK127778, P30DK036836, R01DK132535)
  • National Institute of Environmental Health Sciences (P30ES001247)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
cellular senescence, senescence markers, postmitotic cells, cancer, aging
MeSH terms
Animals, Humans, Organ Specificity, Biomarkers, Cellular Senescence, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review